Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, will travel to Japan in place of Prime Minister Justin Trudeau to attend the funeral of former Japanese prime minister Abe Shinzo.
The Minister will convey Canadians' condolences for the loss of a strong ally and friend, and reaffirm Canada's commitment to our partnership with Japan.
Japan is the world's third-largest economy, with a gross domestic product of $6.2 trillion in 2021. It is one of Canada's most important economic and commercial partners and Canada's largest source of bilateral foreign direct investment in Asia. Canada and Japan are also partners in the Comprehensive and Progressive Agreement for Trans-Pacific Partnership.
Canada and Japan are committed to a rules-based economic order in the Indo-Pacific region and will continue to work together to drive innovation and help meet the world's climate goals.
Quote
"Abe Shinzo was a dedicated leader who brought Canada and Japan closer together during his time as prime minister. On behalf of all Canadians, I extend my deepest condolences to former prime minister Shinzo's family and friends, and to the Japanese people. He will be deeply missed." ? The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry
Quick facts
Minister Champagne was travelling in Japan when the tragic death of Prime Minister Shinzo occurred.
There are over 120,000 people of Japanese origin residing in Canada, and before the COVID-19 pandemic, approximately 300,000 Japanese and Canadians travelled to each other's country annually.
ICIS, a global source of commodity intelligence, has announced the 16th Asian Base Oils and Lubricants Conference will take place in Singapore, 27-28 June 2024. The event offers a platform for senior executives to connect with peers, potential...
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...